P2.17-13 Genome-Wide Copy Number Alterations Profiling Predict Efficacy of Resected Stage II-IIIA Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1539
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV